Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples